Arovella Therapeutics Ltd
ASX:ALA
Arovella Therapeutics Ltd
ASX:ALA
Price:
0.072
AUD
2.86%
Market Closed
Market Cap:
AU$86.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
K
|
Kancera AB
F:3EE0
|
SE |
|
H
|
Hao Tian International Construction Investment Group Ltd
HKEX:1341
|
HK |
|
China Tourism Group Duty Free Corp Ltd
SSE:601888
|
CN |
|
V
|
Valtecne SpA
MIL:VLT
|
IT |
|
Nanfang Communication Holdings Ltd
HKEX:1617
|
HK |
|
I
|
Interhides PCL
SET:IHL
|
TH |
|
Vibrant Group Ltd
SGX:BIP
|
SG |
|
A
|
Allied Copper Corp
XTSX:CPR
|
CA |
|
K Wah International Holdings Ltd
F:KW2
|
HK |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
SelectQuote Inc
NYSE:SLQT
|
US |
|
G
|
Gold Lion Resources Inc
CNSX:GL
|
CA |
|
C
|
Central Plains Environment Protection Co Ltd
SZSE:000544
|
CN |
|
B
|
Bombardier Inc
TSX:BBD.A
|
CA |
|
1
|
1369 Construction JSC
VN:C69
|
VN |
|
Harland & Wolff Group Holdings PLC
LSE:HARL
|
UK |
|
F
|
Fandifi Technology Corp
CNSX:FDM
|
CA |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
R
|
REDS Real Estate Development and Services SA
ATHEX:KAMP
|
GR |
|
Bosideng International Holdings Ltd
HKEX:3998
|
HK |
|
V
|
Vicem Packaging Bimson JSC
VN:BPC
|
VN |
|
Bimini Capital Management Inc
OTC:BMNM
|
US |
|
N
|
Neto Malinda Trading Ltd
TASE:NTML
|
IL |
Cash Flow Statement
Cash Flow Statement
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Currency: AUD
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
4
|
|
| Cash from Operating Activities |
(3)
N/A
|
(4)
-6%
|
(4)
-11%
|
(6)
-59%
|
(7)
-6%
|
(6)
+4%
|
(6)
0%
|
(7)
-8%
|
(6)
+12%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-417%
|
(0)
+41%
|
(1)
-86%
|
(1)
+6%
|
0
N/A
|
0
-89%
|
(0)
N/A
|
(0)
-153%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
7
|
10
|
3
|
6
|
6
|
5
|
8
|
15
|
13
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
|
| Cash from Financing Activities |
7
N/A
|
10
+49%
|
3
-68%
|
6
+97%
|
6
+2%
|
5
-14%
|
8
+41%
|
15
+92%
|
14
-7%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
3
N/A
|
6
+86%
|
(1)
N/A
|
(1)
+41%
|
(1)
-35%
|
(1)
-2%
|
1
N/A
|
8
+502%
|
7
-7%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(3)
N/A
|
(4)
-17%
|
(4)
-4%
|
(7)
-61%
|
(7)
-5%
|
(6)
+11%
|
(6)
-1%
|
(7)
-9%
|
(7)
+7%
|
|
Switch to:
Switch to:
See Also
Discover More
